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INTRODUCTION 
The use of organic arsenicals in diets of swine for 
growth promotant, prophylaxis, and therapeutic effects is a 
common practice. The list of indications for the use of 
organic arsenicals and the benefits derived from them is 
quite substantial but the specific action of these drugs is 
poorly understood. 
Arsanilic acid possesses a wide margin of safety when 
used as recommended. Toxic levels are 10 times the growth 
promotant or prophylactic dosage and 2.5 times the thera­
peutic dosage. Unfortunately, widespread use of arsanilic 
acid in the diets of swine has resulted In cases of 
toxicosis. 
Numerous field cases of arsanilic acid toxicity have 
been investigated and confirmed by the Iowa Veterinary 
Diagnostic Laboratory, Ames, Iowa. In these cases toxicity 
occurred because of indiscriminate or accidental overdosage 
via the feed or because the drug was added to drinking water 
without consideration of arsanilic acid in the ration. 
Toxicosis has also occurred from the proper administration 
of a therapeutic dose to pigs with severe diarrhea. In 
these field cases a syndrome of Incoordination and 
paraparesis was observed. Preliminary histopathologic 
studies indicated that clinical signs were caused in part 
by demyelinatlon of peripheral nerves. 
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There is a paucity of published information on aom© 
aspects of arsanllic acid toxicosis such as arsenic content 
of nervous tissue and Its relationship to the pathogenesis 
of peripheral neuropathy. Also data on possible retention 
of arsenic in edible tissues following prolonged Ingestion 
of toxic levels of arsanllic acid are of public health 
interest. In view of the desirability for more complete 
information in these areas, experimental production of 
arsanllic acid toxicity in swine was undertaken in order to: 
1. more fully characterize the clinical syndrome, 
2. ascertain the gross and microscopic lesions, 
3. determine the location of arsanllic acid in certain 
tissues, 
4. assay arsenic content of tissues at various stages 
of the toxic syndrome, 
5. measure the levels of arsenic retained in tissues 
after cessation of prolonged ingestion of toxic 
dose, 
6. describe possible mechanisms of arsanllic acid 
toxicosis, and 
7. propose a pathogenesis of peripheral neuropathy. 
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REVIEW OP LITERATURE 
Various forms of arsenic, both organic and Inorganic, 
have been used for many years for medicinal purposes as a 
general tonic as well as a treatment for specific diseases 
in man and animals. The medicinal virtues of these agents 
have been acclaimed for some 2000 years, however, the 
efficacy of these drugs by modern standards would probably 
cause their early usage to be classified as empiric. 
Arsenicals were used for the treatment of syphilis, 
tuberculosis, malaria, diabetes, asthma, rheumatism, 
arthritis, neuralgia, anorexia, skin diseases, and blood 
disorders, Vallee et. Èl' (i960), and Frost (1967). During 
the Middle Ages arsenic gained fame as a criminal poison, 
Goodman and Oilman (1956)- In modern times Inorganic 
arccnicals are used in many industrial and commercial 
activities. They are used in the manufacture of glass, 
metal alloys, and paper. Many pesticides, herbicides and 
defoliants contain inorganic arsenic. 
In the United States organic arsenicals were made 
commercially available for animal feeding in 1945. By 1964 
it was estimated that about 50 percent of the swine and 90 
percent of the chickens raised were fed some form of 
organic arsenical (Reuber, I966). 
There are many reports in the literature regarding the 
effects of feeding organic arsenicals to poultry and swine 
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(Frost et al., 1955). To date no one has been able to assign 
a nutritional role to these compounds. The value status 
which arsenicals have achieved in animal production can 
only be Justified on the basis of disease control. The 
factor of disease control perhaps explains the wide variation 
in growth promoting ability of the organic arsenicals as 
reported in the literature. 
Morehouse and Mayfleld (1946) studied the effect of 
4-hydroxyphenylarsonlc acid and 3-nltro-4-hydroxypheny-
larsonlc acid on experimental coccidiosis infection in 
chickens. These two compounds were effective In reducing 
hemorrhage and mortality from the coccldium Elmeria tenalla 
when given as a preventive in drinking water. 
The first reports of growth promoting effects of 
arsenicals appeared In the literature in 1949. Bird e^ aJ, 
(1949) and Morehouse (1949) found that the addition of 
organic arsenicals to diets of chickens not only Improved 
health but also increased feed efficiency. Morehouse 
(1949) also claimed an average of 15.I days earlier egg 
production over control birds. The 3-nltro-4-hydroxypheny-
larsonlc acid was the effective form used In these experi­
ments . 
Carpenter (1951) reported Investigations on the effect 
of 3-nitro-4-hydroxyphenylarsonic acid on growth of swine. 
Dietary levels uf .005, .01 and ,02 percent stimulated 
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growth of weaned pigs. These pigs were reported to have 
smoother and glossier hair coats than controls. Symptoms 
of toxicity were observed at the .01 and .02 percent levels 
after 2 to 4 weeks. With toxicity, growth rate decreased 
due to interference with ingestion of feed. In the same 
report. Carpenter indicated that In trials using 3-nltro-4-
hydoxyphenylarsonlc acid and arsanlllc acid at the 0.005 per­
cent level, no growth stimulation occurred in pigs. 
Becker e_t aJ. (1952) suggested that responses to 
arsenic supplementation depend upon the disease level in 
the herd the same as growth responses to antibiotics. 
Bridges e^ (1954) reported two experiments involving 84 
weanling pigs in which bacitracin, penicillin and arsanlllc 
acid were fed singly or in combination. None of these 
substances significantly increased the growth rates above 
the controls in either experiment. However, in the second 
experiment a significant improvement in feed efficiency 
occurred in all groups. The authors pointed out that all 
of the experiments were conducted under excellent sanitary 
conditions which may account for the failure of the supple­
ments to produce a marked Increase in growth rate. 
In a study with baby pigs fed purified diets Schendel 
and Johnson (1955), showed that when the diet contained 
0.009 percent of arsanlllc acid pigs gained a total of 6.l6 
kg over a four-week period as compared with a gain of 4.l6 
6 
kg for control pigs. 
Hanson e_t aJ. (1955) did a study with 80 pigs fed 
arsanillc acid from weaning to market weight at 0.0033 to 
0.01 percent level. Growth rate was Improved with the 
arsanillc acid but the differences were not considered 
significant. There were no differences In feed efficiency 
due to feeding arsanillc acid. 
A study of the Influence of environment on the response 
of chickens to growth stimulants was conducted by Morrison 
et al. (1954). In two groups of $0 chickens In an old and 
new environment 3-nltro-4-hydroxyphenylarsonlc acid and 
penicillin both produced significant growth responses In 
the old environment only. In the new environment only 
penicillin produced a significant growth response. No 
growth response was obtained with arsanillc acid alone in 
either environment. The level of each of the drugs was as 
follows, 3-nitro-4"hydroxyphenylarsonic acid 90 gm per ton 
feed, arsanillc acid 90 gm per ton feed, and penicillin 10 
gm per ton feed. 
McDonald (1955) also reported the failui• of arsanillc 
acid to give an active growth response in chickens under 
conditions in which penicillin did. 
Libby and Schaible (1955) noted a steady decline in 
the apparent efficiency gained from feed additives. They 
contend that this was not due to a buildup of resistant 
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organisms but rather to an overall improvement of the 
environment. Control animals benefited from feeding anti­
biotics and arsenicals by being exposed to a lower level 
of potential organisms. Evidence presented indicated an 
overall Improvement in performance of control animals over 
a four year period. This report further substantiates the 
idea that growth promoters act primarily by reducing the 
level of disease agents in a group of animals rather than 
as a specific growth stimulant. 
The organic arsenicals have been widely used in swine 
for prevention and treatment of swine dysentery. Boley et 
al. (1951) reported on the efficacy of arsanilic acid in 
controlling a natural outbreak of swine dysentery. Robinson 
(1951) used arsonic acid derivatives for the same purpose. 
Carpenter and Larson (1952) reported that the arsenicals, 
3-nltro-4-hydroxyphenylar3onic acid and 4-nitro-pheny-
larsonic acids had a prophylactic and curative effect on 
swine dysentery when administered via the drinking water. 
These compounds however, did not prevent recurrence of the 
disease. Smith e_t (I96I) used arsanilic acid at a 
level of 250 parts per million in feed or 175 parts per 
million in drinking water as a therapeutic and prophylactic 
agent for swine dysentery. These levels were effective in 
reducing the incidence of scours, lowering mortality and 
improving feed efficiency. 
a 
Peed Additive Compendium (1969) lists the approved 
level of arsanilic acid as 45 to 90 gm per ton of feed to 
stimulate growth and improve feed efficiency in growing 
swine. Levels of 225 to 36O gm per ton are permissable for 
5 to 6 days for control of swine dysentery. 
In an attempt to explain the toxicity of pentavalent 
organic arsenicals the idea of degradation and reduction to 
inorganic trivalent forms has been perpetuated. Voegtlin 
and Thompson (1923) studied the differences in toxicity and 
parasiticidal activity of trivalent, pentavalent and 
arsenobenzene types of arsenicals. They believed that dif­
ferences in activity were due to the change of these com­
pounds into trivalent oxides and that their effectiveness, 
as parasiticides, was determined by the rate of this change. 
Eagle and Doak (1951) reported on the parasiticidal activity 
of arsenoso versus arsonic acids. They indicated that 
arsenoso compounds have direct activity while arsonic acid 
became active by virtue of conversion to arsenoso in the 
animal body. The arsenoso compounds are trivalent and the 
arsonic acids pentavalent compounds. 
Moody and Williams (1964) studied the fate of arsanilic 
acid and acetylarsonic acid in hens. They found that 
arsanilic acid was excreted unchanged by hens and that 
there was no evidence that arsanilic acid was changed to 
any other compound or converted to inorganic arsenic. 
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Evidence was based on paper chromatographic characteristics 
of arsanilic acid and excretion products. 
Overby and Predrickson (1963) and Overby and Straube 
(1965) studied the metabolic stability of arsanilic acid 
used in medicated feeds of chickens. The l4C:7^As Isotope 
ratio was determined in tissues, organs and excreta of 
chicks given doubly labeled arsanllic-l-l^C-T^As acid. The 
method used was sensitive enough to detect metabolic degrada­
tion of the compound to inorganic arsenic because as little 
as 1 percent of arsenate-74As added to the dose resulted in 
significant increases and decreases in isotope ratios in 
the tissues. Trace quantities of orally administered 
inorganic arsenate were selectively retained in the tissues. 
In four chicks consistent changes were not observed 24 hours 
after the last dose of arsanilic-1-14C-74AS acid. Arsanilic 
acid was found unchanged in excreta and neither arsenate 
metabolic products nor reduced forms of arsanilic acid were 
found In the tissues. 
Overby and Predrickson (1965) studied the localization 
and type of arsenic excreted and retained by chickens fed 
74As-labeled arsanilic acid, sodium arsenate and sodium 
arsenite. The nature of transport forms of arsanilic acid 
and inorganic arsenate were compared by paper chromatography, 
paper electrophoresis, and ion exchange chromatography. 
Arsanilic acid was excreted faster than inorganic forms and 
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hau lésa affinity for body tissues. The biological half-
life of araanlllc add In blood was about 36 hours compared 
to more than 60 hours for arsenate. Two forms of "tissue-
bound" arsanilic acid and three of arsenate were characterized. 
None of the arsenate products was found in the arsanilic acid 
fed birds. One "tissue-bound" form, compound A, was found 
in proventricular lining and feathers, and was convertible 
to arsanilic acid with NaOH. The second "tissue-bound" form, 
compound B, was chemically very similar to arsanilic acid. 
It was found as the only radioactive component in kidney and 
liver. Bile and intestinal contents contained compound B 
and arsanilic acid in equal proportions while excreta con­
tained arsanilic acid and only trace amo^mts of compound B. 
Since the effectiveness of a drug is dependent upon the 
length of time which it is retained in the body, the rate 
and route of arsenical elimination is Important. In general, 
from the literature, it would appear that the organic 
arsenlcals are poorly absorbed from the digestive tract but 
once absorbed they are quickly excreted primarily by the 
kidneys. When these same compounds are given parenterally 
they are rapidly eliminated In urine and to a lesser extent 
In feces. 
Voegtlln and Thompson (1923) using rats, reported that 
from 80 to 90 percent of the arsenic in the organic penta-
valent compounds was eliminated in the urine within the first 
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6 hours following intravenous injection. They believed 
that organic pentavalent compounds were excreted unchanged. 
Hogan and Eagle (1944) found that as much as 40 per­
cent, of pentavalent organic arsenicals injected intra­
venously into rabbits, was excreted in the urine within 
1 hour. 
After Intravenous Injection of four forms of organic 
arsenicals into rabbits, Chance et aJ. (1945) found that 
the ratio between the total amounts of arsenic excreted in 
the urine and feces varied widely but the urinary output 
predominated in all experiments. Arsonic acids were 
cleared from the body more rapidly than the corresponding 
arsenoxides. Of the latter, unsubstituted phenylarsenoxide 
was the more slowly excreted, Crawford and Levvy (194?) 
found that 90 percent of the phenylarsonic acid injected 
intravenously in rabbits was excreted in the urine. 
In contrast to previous reports on the routes of 
excretion for pentavalent organic arsenicals, Overby and 
Prost (i960), reported that following feeding of arsanilic 
acid to swine, at levels of 30, 60,and 90 gm per ton of 
feed, more of the arsenic was excreted in feces than In 
urine. It should be noted that these forementioned studies 
involved the Injection of arsenicals rather than oral 
administration. 
Moody and Williams (1964) found that arsanilic acid 
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was more rapidly excreted by hens after Intramuscular 
Injection than after oral dosing. At an oral dose level 
of 50 mg/kg approximately 64 percent of the dose was 
excreted in 1 day while after Injection of the same dosage 
approximately 83 percent was excreted in 1 day. They 
suggested that arsanilic acid was poorly absorbed by the 
hen. Acetylarsanilic acid given orally in doses of 50 mg/kg 
was largely excreted unchanged, but a small proportion, 5 to 
6 percent, was deacetylated to arsanilic acid. However, if 
acetylarsanilic acid was injected Intramuscularly into hens 
it underwent more extensive deacetylation, 36 percent. This 
occurred only in the kidney. Deacetylation was associated 
with the mitochondrial fraction of kidney homogenates. 
These findings suggested that acetylarsanilic acid was 
poorly absorbed in the hen. 
Arsenic is a transition element, a metalloid. It forms 
alloys with metals and reacts readily with carbon, hydrogen 
and oxygen. Nonmetal properties permit arsenic to form 
divalent, trivalent and pentavalent acids. Arsenic is often 
involved in interactions with compounds of phosphorous, 
sulfur and selenium in biological systems (Frost, 196?). 
Inorganic arsenicals are generally regarded as being 
more toxic than organic and trivalent forms more toxic than 
pentavalent. The most toxic forms are trivalent inorganic 
compounds and the least toxic pentavalent organic compounds. 
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Voegtlin and Thompson (1923) studied the toxicity and 
parasiticidal activity of several arsenicals in relation to 
the rate of their excretion. They found considerable 
variation in the ability to excrete arsenicals between 
individuals of the same species. Trlvalent oxide forms 
of arsenicals were excreted the slowest and pentavalent 
compounds were excreted the most rapid. The rate of 
excretion decreased as the toxicity and parasiticidal 
activity increased. 
Hogan and Eagle (1944) suggested that variability in 
systemic toxicity of arsenicals was primarily determined by 
the degree of binding by the tissues. They found that in a 
series of phenyl arsenoxides, varying twentyfold in toxicity, 
that each was bound by red blood cells vitro in proportion 
to its systemic toxicity. A similar variation was found in 
the aiuount of arsenical bound by circulating red blood cells 
following intravenous injection. Kidney and liver levels 
of arsenic 24 or 48 hours after intravenous injection of 
arsenoxides followed a similar pattern. 
Eagle and Doak (1951) studied the biological activity 
of arsenobenzenes on the basis of their chemical structure. 
They found that phenyl ring compounds were not only less 
toxic when they contained acid radicals but were also less 
effective. Amine-substituted groups however reduced 
toxicity but did not reduce effectiveness. They suggested 
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that toxicity and therapeutic activity of arsenoso compounds 
were determined by the amounts which combined with cellular 
components and that cytotoxic effects were due to reactions 
with sulfhydryl groups of essential enzymes. 
Gordon and Quastel (1948) studied the use of trivalent 
arsenic compounds for the detection of enzyme systems con­
taining reactive thiol groups. They found that pentavalent 
compounds affected hepatic esterase but not other enzymes 
investigated. 
Vallee (I96O), In a review article, described 
some of the enzyme systems with which arsenic may Interfere. 
Cytochrome oxidase, lactic dehydrogenase, sucrose 
phosphorlase and the sulfhydryl enzymes were listed as 
being susceptible to arsenic in some form. 
Hanson e_t (1955) reported that pigs fed arsanillc 
acid retained levels of arsenic in their tissues in relation 
to the amount fed. Hepatic retention was approximately 
twice as high as renal retention. Arsenic retention in the 
muscle, fat, and skin was relatively low with O.37, 0.45, 
and 0.68 wg/gm respectively the highest individual values 
obtained. 
Bruggemann e^ a^. {I963) reported that despite 
Increasing intake of arsanillc acid and other drugs, residues 
in the tissues remained at a constant low level. A linear 
increase did not occur and only a slight Increase In residue 
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was found when drug levels were increased up to 10 times 
recommended levels. Scheidy ejb aj. (1953) was unable to 
produce high levels of arsenic in the tissues of swine by-
feeding l40 mg of sodium arsanilate per 30 pounds of body 
weight daily for one week. In a study of arsenic toxicity 
in cattle. Peoples (1964) found no evidence that arsenic 
was a cumulative poison. He was unable to detect arsenic 
in blood, milk or tissues of cattle fed arsenic trioxide. 
Urinary excretion was nearly equal to daily dietary intake. 
Overby and Frost (1962b) fed chickens acetone-dried 
liver powder made from livers of swine fed arsanilic acid 
at a level of $00 parts per million in the ration. They 
found no evidence of arsenic accumulation in either species. 
A similar study by Overby and Frost (1962a) using rats showed 
no accumulation of arsenic due to ingestion of tissues from 
animals fed arsanilic acid. Calesnick et al. (1966) fed 
human subjects tissues of chickens which were receiving 
arsanilic-74A3 acid in their diets. There was a rapid 
fecal and urinary excretion of 7^As by the participants. 
The same subjects were fed arsanilic-T^As acid and tissue-
74AS with no statistical differences between the urinary and 
fecal recoveries of tissue-Y^As and pure arsanilic-T^As acid. 
It was suggested that arsanilic acid remaining as tissue 
residue was not physiologically different from free arsanilic 
acid. 
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Notzold et al_. (1956) produced experimental toxicosis 
in swine with arsanilic acid. Weanling pigs fed 8 times 
the recommended level for growth promotion developed an 
acute toxicosis characterized by depressed feed intake, 
sanguineous stools, irritability, cannibalism, and complete 
paralysis. Death occurred in an average of 29 days on this 
diet. 
Oliver and Roe (1957) reported a field case of 
arsanilic acid toxicity in swine which had accldently 
been fed 15 times the recommended level for growth promotion. 
The clinical signs observed were varying degrees of incoordi­
nation and some blindness. Consciousness, temperature and 
appetite were not significantly affected. Recovery was 
uneventful following removal of arsanilic acid from the 
diet, however some of the pigs apparently remained blind. 
Jubb and Kennedy (19^3) described poisoning in swine by 
organoarsenicals. Cutaneous erythema, blindness, vestibular 
disturbances, ataxia and hyperaesthesia were listed as 
typical changes. No gross lesions were described. Periph­
eral neuropathy and degeneration of optic nerves and tracts 
were listed as the primary microscopic lésions. 
Harding et a^. (1968) reported findings in experi­
mentally Induced arsanilic acid poisoning in pigs. Clinical 
signs were incoordination, loss of sight, and eventual 
paresis. All animals remained alert and continued to eat 
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as long as they were able to get to the feed. Gross 
lesions were limited to distension of the urinary bladder 
in a few cases of prolonged poisoning. Microscopic lesions 
were essentially the same as described by Jubb and Kennedy. 
Vorhies e_t aJ. (1969) investigated decreased water 
consumption as a factor affecting the toxicity of arsanilic 
acid for swine. Pigs fed 19 percent protein diets con­
taining 0.02 percent arsanilic acid and given water varying 
quantitatively from 120 ml dally to 1,644 ml daily had no 
signs or lesions of arsenic toxicosis. Typical signs and 
lesions of toxicosis were produced in two pigs given amounts 
of arsanilic acid equivalent to 0.10 percent of the diet 
while water consumption was restricted. It was suggested 
that the quantity of water consumed may be a factor in 
arsanilic acid toxicity. 
Peterson and Murray (1965) described three basic types 
of peripheral demyelination experimentally produced in tissue 
cultures of fetal rat dorsal root ganglia, Demyelination 
was produced by crushing injury, diphtherial toxin or 
thallium poisoning. Crushing Injury produced typical 
Wallerlan degeneration with primary damage to the axon and 
its myelin sheath. 
Diphtherial toxin produced segmental demyelination with 
primary damage related to individual Schwann cells. The 
myelin lesions were scattered with neighboring segments of 
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myelin undamaged. With continued exposure to diphtherial 
toxin or with higher levels demyelination was Increased 
and neuronal damage began to appear. The pattern of 
demyelination changed to a Wallerlan type when neuronal 
damage was produced. 
Thallium poisoning caused a vacuolization of axons 
without disruption of the myelin sheath. Prolonged 
exposure to thallium produced degeneration of neuronal 
somas, breakdown of myelin and death of Schwann cells. 
It was concluded that neurona] somas, axons, and 
Schwann cells differed in their individual sensitivity 
and response to particular toxic agents. Also that damage 
to one will influence the behavior of the others in ordered 
time sequence and result in different patterns of 
demyelination. 
Yonezawa and Iwanami (1966), produced thiamine 
deficiency in cultured nervous tissue by application of 
the antimetabolites, oxythiamine and pyrithlamine. Depending 
upon the concentration of antimetabolites, deficiency changes 
were classified basically into two groups, acute and chronic. 
The acutc form exhibited necrotic changes of neuron somas, 
ollgodendroglla, Schwann cells and satellite cells. Myelin 
sheaths were also damaged in a characteristic fashion, which 
differed from the Wallerlan type of degeneration. In the 
chronic form degeneration of myelin sheaths was the major 
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change and it was Initiated in the area close to the 
Schwannian nucleus on peripheral fibers. It was inferred 
that nerve cells and myelin sheaths have a different thresh­
old and tolerance for thiamine deficiency and that the major 
metabolic background of thiamine utilization in myelin-
supporting cells differs from that of neuron somas. 
Fullerton (1966) produced chronic peripheral neuropathy 
by lead poisoning in guinea-pigs. The most common histo-
pathological change noted was a mixture of segmental 
demyelination and axonal degeneration. In some animals 
only segmental demyelination was found and in others axonal 
degeneration was the sole finding. When both demyelination 
and axonal degeneration occurred in the same fiber it was 
indistinguishable from Wallerian degeneration. It was 
suggested that large heavily myelinated fibers were more 
severely affected than small lightly myelinated ones. 
Pleasure et. Si- (1969) reported that axoplasmic flow 
was interrupted in cats with neuropathy induced by 
acrylamide. It was not interrupted in normal cats or in 
cats with neuropathy induced by tri-orthocresyl phosphate. 
Axoplasmic flow was determined by injections of trltiated 
L-leucine and autoradiography. Proteins flowed from lumbo­
sacral motor neurons along the ventral roots and from 
ganglion cells toward the spinal cord along the dorsal 
roots at about 1.5 mm per day. Transport of Intracellular 
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proteins from site of synthesis to site of f-unction is 
accentuated in motor neurons by the extreme length of their 
axonal processes. It was hypothesized that interruption 
of protein transport could cause axonal degeneration. 
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MATERIALS AND METHODS 
Experimental Animals and Housing 
Swine were obtained from the Iowa State University Swine 
Nutrition Farm, Ames, Iowa. 
Animals for Trials I, H, and III were selected for uni­
formity of size without regard to sex. They varied in 
weight from 36 to 4l pounds. These animals were housed in 
isolation units at the Veterinary Medical Institute, Iowa 
State University. 
Animals for Trial IV were selected to provide minimum 
size with maximum maturity. Two pigs, 6 weeks of age and 
weighing 11 and 12 pounds each were utilized In this trial. 
The pigs were housed in isolation quarters approved for 
radioisotope research, located in the Department of 
Veterinary Microbiology, Iowa State University. Each animal 
was held In a wire cage which was placed over a steel pan 
lined with a double layer of plastic in order to facilitate 
the collection of urine. To further contain the radioisotope 
a heavy sheet of plastic, 8' x 12', was placed on the con­
crete floor under the animal which received radioactive 
material. 
Experimental Ration 
Arsanlllc acid was provided by Salsbury Laboratories, 
Charles City, Iowa, as a 10 percent arsanlllc acid in a 
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corn meal carrier. Two po'unds of 10 percent arsanilic acid 
were added to 198 pounds of a standard 16 percent protein 
grower ration and mixed in a rotating drum for 8 minutes. 
Random samples of feed containing the drug and drug-free 
feed were analyzed for arsenic content. The experimental 
ration had 900 gm of arsanilic acid per ton which was 10 
times the recommended prophylactic level. 
The standard ration used in this study was obtained 
from the Iowa State University Swine Nutrition Farm. 
Ingredients 
Dicalcium phosphate 
Ground yellow corn 
500 soybean oil meal 
Vitamin premix 
Calcium carbonate 
78.25 
18.50 
0.50 
0.90 
1.25 
Iodized salt 0.50 
Trace mineral mix 0.10 
100.00 lbs. 
Calculated analysis 
Protein 
Calcium 
Phosphorus 
16.14# 
0.72* 
0.54$ 
Vitamin A 
Riboflavin 
Vitamin D2 
1532 I.U. 
300 I.U. 
2.6 mg 
23 
Ca Pantothenate 6.8 mg 
Niacin 18.2 mg 
Choline chloride 407.0 mg 
Vitamin B12 10.0 meg 
Tritium Labeled Arsanilic Acid 
Arsanilic acid^ was custom labeled with tritium by New 
England Nuclear^ with a catalytic exchange labeling technique. 
The custom labeled material was purified by thin layer 
chromatographic procedures. Purified tritium labeled 
arsanilic acid containing 3 millicurles of radioactivity 
was mixed with nonlabeled arsanilic acid to make a 10 ml 
solution containing 200 mg of arsanilic acid . 
Necropsy Procedures 
Animals from Trials I, II, and III were stunned with 110 
volt AG electric shock and exsanguinated by severing the 
subclavian arteries and veins. 
In order to collect and fix tissues as quickly as 
possible two people performed all necropsies. The head was 
disarticulated at the atlas and one person removed the brain 
and optic nerves while a second person removed the spinal 
^Abbott Laboratory, North Chicago, Illinois. 
2 New England Nuclear, Boston, Massachusetts. 
•3 
Procedures carried out by Dr. J. J. O'Toole, Depart­
ment Veterinary Pathology, Iowa State University, Ames, Iowa. 
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cord and major peripheral nerves. 
To expose the spinal cord and dorsal root ganglia the 
following technique was devised. The carcass was positioned 
on the ventral abdominal surface with the limbs spread apart 
for support. A deep incision was made from the tail head 
to the anterior cervical vertebrae. The muscles were 
dissected away from dorsal and lateral spinous processes 
and displaced laterally to expose the dorsal aspects of 
the spinal column. A light weight meat cleaver was used to 
cut away the dorsal arch of the spinal canal, starting at 
the cervical vertebrae and working caudad. As the cutting 
proceeded the dorsal aspect of the spinal column was 
reflected away from the carcass to aid in controlling the 
depth of the cut. With care and practice the spinal cord 
and dorsal root ganglia could be exposed undamaged in 
minutes after death of the animal. Routine necropsy tech­
niques were used for the remainder of the carcass. 
Tissues collected for arsenic determination were sealed 
in plastic cups and frozen. Samples of liver, kidney, 
skeletal muscle, rib, blood, spinal cord, peripheral nerves, 
cerebellum, cerebrum, and brain stem were collected. 
Tissues collected for histopathologic evaluation were 
fixed by immersion in 10 percent buffered formalin. Periph­
eral nerves were pinned to a paraffin sheet prior to 
immersion in formalin to reduce contraction and distortion 
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during fixation. Brain, spinal cord, dorsal root ganglia, 
sciatic nerves, obturator nerves, femoral nerves, radial 
nerves, optic nerves, liver, kidneys, adrenal glands, 
lung, pancreas, stomach, duodenum, lymph nodes, spleen, 
skin, heart, and skeletal muscles were collected from 
each animal in Trial I. 
Pigs from Trial IV were anesthetized with sodium 
pentobarbital and killed by exsanguination. Necropsy 
techniques were used as described above with slight varia­
tions required for safe hanaling of radioactive materials. 
The necropsy was done on a double; layer of plastic sheeting. 
All radioactive tissues and contaminated disposable supplies 
were wrapped in double sheets of plastic and placed in 
plastic bags for disposal of by the Radiological Safety 
Group. The work area and contaminated Instruments were 
washed with Radiacwash" and water. 
Samples of liver, kidney, spinal cord, cerebrospinal 
fluid and bile were collected for liquid scintillation 
counting. Control animal tissues were not collected for 
liquid scintillation counting. 
Samples of kidney, liver, spinal cord, dorsal root 
ganglia, optic nerves, optic tracts, and peripheral nerves 
were collected for autoradiographic procedures. One set 
^Atomic Products Corporation, Long Island, New York. 
26 
of tissues was fixed In 10 percent buffered formalin and 
one set was placed in glass vials and quick frozen by 
immersion in liquid nitrogen. 
Histologic Procedures 
Tissues were fixed in formalin, embedded in paraffin, 
sectioned at 6 la and stained with Harris hemotoxylin and 
eosin Y. 
Selected sections of peripheral nerves were stained by 
Bodian's method for nerve fibers and nerve endings (Bodian, 
1936). This method selectively stained axons black thus 
making it easier to Identify axonal fragmentation. 
Arsenic Analysis 
Arsenic residue in tissues of swine fed arsanillc acid 
was measured as total arsenic. The technique was described 
by Winkler (1962) for the determination of total arsenic 
in biological materials. 
Tissue samples of 1 to 10 gm In weight were digested 
in nitric and sulfuric acids to volatilize all free 
chlorides and thus prevent the loss of arsenic as As Clg. 
The final digestate was placed in an arslne generator and 
the arslne gas captured In silver dlethyldithlocarbamate 
in pyridine as AsH^. Arsenic determinations were made by 
measuring absorbance at $40 mu with comparison to a standard 
curve. 
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Statistical Methods 
Arsenic content of the various tissues from pigs within 
the 9 time periods was analyzed using analysis of variance 
techniques. The primar" sources of variance to be investi­
gated were: tissues, time periods, and the interaction of 
tissues by time periods. Sums of square and mean squares 
for these sources were used as indicators of existing dif­
ferences among mean arsenic content of subgroups within 
each source. Appropriate P-tests were made in order to 
determine significant mean differences within each source 
of variation. Since arsenic content determinations were 
made on 10 tissues from each pig the statistical analysis 
was of the split-plot design with pigs treated as plots 
(units) and tissues from pigs as subplots (subunits). 
Scintillation Counting Procedures 
Radioactivity of the various tissues and fluids was 
measured by liquid scintillation counting using a Packard 
trl-carb liquid scintillation spectrometer^. 
Samples of 0.05 ml whole blood, 0.1 ml urine, 0.5 ml 
cerebrospinal fluid, 0.1 ml serum, .05 ml clotted blood, 
and 0.1 ml bile respectively were solubiliaed in NCS^. 
^Packard Instrument Co. Inc., Downers Grove, Illinois. 
p 
Amersham Searle. Des Plaines, Illinois. 
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NOS solubllized samples were counted in l8 ml of PPO-
POPOP^ scintillator solution (50 parts PPG and 0.625 parts 
POPOP in toluene). 
Tissues were prepared for scintillation counting by 
2 
maceration with scissors followed by digestion in Hyamine . 
Paired samples of 50 mg kidney, 50 mg liver, and 100 mg 
spinal cord respectively, were digested in 1 ml of 
Hyamine. The digested samples were counted in l8 ml of 
scintillator solution made up by mixing 8 gm PPO, 0.6 gm 
dimethyl POPOP, 150 gm naphthalene, 100 ml 2-ethoxyethanol 
and 20 ml ethylene glycol q.s. in 1-4-dloxane to 1 liter. 
Autoradiographic Procedures 
Samples of optic nerve, optic tract, sciatic nerve, 
lumbosacral cord, dorsal root ganglia, kidney and liver 
were placed in glass vials for quick freezing in liquid 
nitrogen. Frozen sections were cut at 8 u in a cryostat 
at -15° to -20° C and mounted directly from the microtome 
knife onto glass slides. The tissue sections were air dried, 
fixed in acetone for 10 minutes then air dried for 6 hours 
at room temperature. After drying for 6 hours the slides 
were dipped in NTB-3'^ nuclear track emulsion, diluted 1:2 
^PPO, 2-5 diphenyloxazole; POPOP, Para-bia [-2-(5 
Phenylozazolyl)] benzene. 
2 Packard Instrument Co. Inc., Downers Grove, Illinois. 
^Eastman Kodak Co,. Rochester, New York. 
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in distilled water, dried in the air and packed in light-
proof boxes with a drying agent. 
Tissue samples, from areas adjacent to those mentioned 
above, were fixed in 10 percent buffered formalin, paraffin 
embedded, cut at 5 u on a microtome, mounted on glass slides 
and dried in an oven at 80° C for 6 hours. These sections 
were deparaffinized in xylene, rehydrated, then dipped in 
NTB-3 nuclear track emulsion as described above. 
After exposure for 27 days at 5*^ C the autoradlograms 
were developed for 2 minutes, in Dektol^ diluted 1:2 in 
distilled water, at 15° C and fixed for 8 minutes. Developed 
autoradlograms were stained through the emulsion with Harris 
hematoxylin and eosin Y stain and permanently mounted. 
Experimental Design 
Trial I 
Continuous high level feeding of arsanillc acid Thirty 
pigs, average weight 38 pounds, were placed in 10 groups of 
3 pigs each. Nine groups were fed a ration containing 900 gm 
of arsanillc acid per ton and a control group was fed the 
same basic ration without the drug. The animals were housed 
in pens with concrete floors. Peed and fresh water were 
available free choice. 
All animals were examined dally and the following obser-
^Eastman Kodak Co., Rochester, New York. 
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vations recorded: appetite, stools, hearing, vision, 
sensitivity to touch, muscular coordination, and body 
temperature. 
Hearing was evaluated by making a noise and observing 
the response. Vision was evaluated by moving a white towel 
slowly past the pen being careful not to attract attention 
by sound or air currents. Turning the head in the direction 
of the moving object was considered evidence of vision. 
Coordination was evaluated by observing the gait and by 
manual manipulation of the animals forcing them to regain 
balance or fall to one side. Sensitivity to touch was 
tested by probing the animals with the fingers or a wooden 
pointer In areas of the body away from the pigs field of 
vision. 
One group of three pigs was killed and necropsled on 
day 4, 7, 10, 13, lo, 19, 21, 23, and 2? after the initiation 
of continuous arsanlllc acid feeding. Histopathologic 
evaluations and arsenic determinations were performed on 
tissues from each pig. 
Trial n 
Withdrawal of arsanlllc acid after high level feeding 
This trial was designed to determine if pigs fed 
arsanlllc acid at 10 times the recommended level would 
require longer than the specified 5 day withdrawal period 
to reduce tissue levels of arsenic to acceptable concentra-
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tlons. 
Six pigs, average weight 40 pounds, were fed a ration 
containing 900 gm of arsanilic acid per ton. The ration 
was fed free choice with access to fresh water. On the 
20th day this feed was replaced by an arsanilic acid free 
feed. Two pigs were killed and subjected to necropsy on 
days 3, 6, and 11 after withdrawal of the drug. Kidneys, 
liver, skeletal muscles, from the medial thigh, blood, rib, 
spinal cord, peripheral nerves and brain from each pig were 
assayed for arsenic content. 
Trial III 
Clinical recovery study This trial was designed to 
determine if pigs which had developed severe posterior 
paresis, due to arsanilic acid poisoning, could recover 
within a reasonable period of time. 
Six pigs averaging 40 pounds were fed a ration con­
taining 900 gm of arsanilic acid per ton. The ration was 
fed free choice with access to fresh water. Examinations 
and observations were performed daily as described in 
Trial I. 
When an animal developed posterior paresis to the 
extent that it was reluctant to, or unable to rise to a 
standing position the pig was placed on an arsanilic acid 
free ration. Pigs were killed and necropsied on day lo. 
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1 2 ,  17, 20, 32, and 38 following the change in diet. Prior 
to death each animal was examined for any change in 
clinical condition. Gross lesions were evaluated at 
necropsy. 
Trial W 
Studies with tritium labeled arsanilic acid Two 
pigs, six weeks of age and weighing 5 and 5.5 Kg each, 
were used for this study. Peed was withheld from both 
animals for 24 hours preceding and for 24 hours during this 
study to reduce fecal output. 
The smallest pig received the trltiated arsanilic 
acid in order to achieve maximal levels of radioactivity in 
the tissues with the limited supply of labeled drug. A 
total dose of 200 mg arsanilic acid containing 3 mC radio­
activity was administered Intravenously in two injections 
12 hours apart. This dose was equal to 40 mg arsanilic 
acid and 600 mC radioactivity per kg body weight. The 
control animal received 40 mg arsanilic acid per kg body 
weight but no radioactivity. 
A 0.10 ml sample of blood was taken hourly from the 
ear vein of the test animal for the first 12 hours. A 50 
ml syringe was used to collect and measure the urine 
excreted each hour for the first 12 hours. Urine excreted 
in the second 12 hour period was collected and measured at 
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the end oT the study. The contents of the urinary bladder 
at necropsy were added to the final collection. No blood 
or urine was collected from the control animal. 
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RESULTS 
Trial I 
Continuous high level feeding of arsanilic acid 
Clinical signs The clinical signs observed in this 
trial reflected the variability in the response of a 
biological system to a stimulus. Due to this variation 
in response the clinical signs described are qualitative 
rather than quantitative. In describing the sequence of 
events in the toxic syndrome the observance of a particular 
clinical sign in one individual was considered to be the 
onset even though the same sign might not manifest itself 
in the entire group for several days. 
Several pigs developed a roughened hair coat on day 3 
of the experiment. Within 24 to 36 hours these animals 
had a mild diarrhea characterized by fluid stools. This 
condition persisted for 2-3 days and was followed by con­
stipation with firm feces coated with excessive amounts of 
mucus. Following this transient diarrhea, of 2-3 days, 
normal stools were noted for the remainder of the experiment. 
Cutaneous hyperemia and hyperesthesia were evident in 
several animals by day 5. Since all pigs were white, 
cutaneous hyperemia could readily be detected. Hyperesthesia 
was manifested by the pigs squealing and becoming excited 
when handled or probed. As early as day 6 several pigs 
that had cutaneous hyperemia and hyperesthesia were mildly 
35 
Incoordlnated. When these animals were forced to run around 
the pen, they moved with a swaying gait often slipping and 
staggering when attempting to change direction. Manual 
manipulation caused these animals to make exaggerated 
movements in regaining balance. 
In this experiment, feeding high levels of arsanilic 
acid did not seem to affect the pigs appetite. It was 
noted, however, that with the onseo of incoordination many 
animals had difficulty with prehension of feed and water. 
This was seen in the majority of the animals that became 
toxic. These same animals would eagerly Ingest food and 
water placed in their mouths. Several animals were main­
tained by hand feeding for up to 10 days after loss of 
prehensile ability. 
Signs of incoordination became progressively more 
severe and by day 15 several animals had developed posterior 
paresis. These pigs could rise to a standing position with 
difficulty and would do so only when prodded. They pre­
ferred to rise on the fore feet and remain in a sitting 
position while eating or drinking (Figure l). Several pigs 
had quadriplegla by day l8. The characteristic repose was 
with the fore limbs drawn posteriorly and the hind limbs 
drawn anteriorly (Figures 3 and 4), Some pigs with quadri­
plegla remained on one side and made vain attempts at 
righting themselves (Figure 2). All animals in this trial 
Figure 1, Pig with posterior paresis in typical sitting 
position. Animal had been fed arsanilic acid 
(900 gm/ton) for I8 days 
Figure 2. Pig with quadriplegia lying in lateral 
recumbency. Animal had made vain attempts 
at rising to an upright position, Arsanilic 
acid (900 gm/ton) had been fed for 20 days 

Figure 3. Pig with quadrlplegla following 20 days of 
feeding arsanillc acid (900 gm/ton). The pig 
had developed posterior paresis on the 17th 
day of Trial I 
Figure 4. Pig with advanced quadrlplegla manifested by 
nearly total lack of muscle control in the 
limbs. The pig had been fed arsanillc acid 
(900 gm/ton) for 25 days 
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remained bright and alert and responded to auditory stimu­
lation. One animal wandered aimlessly as though blind but 
attempts to prove blindness by quietly moving a white 
towel past the animal were inconclusive. Several pigs 
developed a peculiar head tilt. The direction of the tilt 
was inconsistent and no special significance could be 
assigned to it. 
No unusually high or low rectal temperatures were 
recorded. There was a range of daily fluctuation between 
101° to 104° P. 
The onset of clinical signs In relation to the length 
of time that toxic levels of arsanlllc acid were fed is 
Illustrated in Table 1. Clinical signs from day 20 through 
day 27 were essentially the same as those recorded on the 
20th day. 
Arsenic residue Arsenic content determinations were 
made on tissues from each pig in Trial I. The mean arsenic 
content of 10 tissues is presented in Table 2. 
Statistical analysis of the data in Table 1 is presented 
In Table 3. Significance was tested with the P-test at the 
.01 level. The P-values indicate a significant difference 
in: (l) mean arsenic content of tissues among the time 
periods, (2) mean arsenic content among the various tissues, 
and (3) time trends of mean arsenic content of tissues. 
Table 1. Sequence of onset of clinical signs of toxicosis in pigs fed arsanlllc 
acid at 10 times the recommended prophylactic level 
Days fed arsanlllc acid at 900 gm/ton ration 
^ 3 9 5 B 9 n 11 13 14 15 15 I? IB I9 2^ 
Rough hair + + + + + + + + + + + + + + + + + + 
coat 
Diarrhea + + + + + 
Firm feces + + + + + + + + + + + + + + 
Cutaneous + + + + + + + + + + + + + + + + 
hyperemia 
Hyperesthesia + + + + + + + + + + + + + + + •}-
Incoordination + + + + 4- + + + 4- + + + + + + 
Posterior + + + + -I- + 
paresis 
Quadriplegla + + + 
Table 2, Arsenic levels® in tissues of pigs fed arsanilic 
acid at 900 gm/ton ration 
Days 0 4 7 10 13 
Kidney- T° 5.92 6.27 6.67 15.70 
Liver T 5.50 7.73 7.57 10.93 
Muscle 0.41 1.17 0.56 0.67 
Blood T 1.65 1.70 1.81 2.98 
Rib N 0.35 0.51 0.37 0.89 
Peripheral 
nerve T 0.60 1.20 0.97 1.06 
Spinal 
cord T 0.26 0.36 0.42 0.59 
Brain stem T 0.37 0.38 0.69 0.93 
Cerebellum T 0.24 1.03 0.68 0.74 
Cerebrum N 0.18 0.34 0.49 0.63 
Time period 
means 1.547 2.068 2.023 3.513 
&Data in each group represents a mean tissue level in 
parts per million from three pigs. 
^Overall tissue means averaged over time periods 
exclusive of control animals. 
°Trace—less than 0.02 ppm. 
^Negative to test. 
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16 19 21 23 27 Means^ 
8.38 8.33 6.30 6.13 10.03 8.192 
9.83 9.67 4.57 5.63 5.81 6.360 
0.61 0.92 0.48 0.44 0.50 0.640 
2.10 1.94 1.03 1.23 1.73 1.797 
0.77 0.46 0.34 0.32 0.53 0.504 
1.53 1.57 1.01 0.96 1.15 1.117 
0.99 0.74 0.84 0.79 0.75 0.638 
1.06 1.04 1.09 0.89 1.14 0.863 
1.27 1.23 1.45 1.11 1.00 0.972 
0.74 0.82 1.14 1.10 0.93 0.597 
2.728 2.672 1.826 1.861 2.359 
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Table 3. Statistical analysis of arsenic content of tissues 
in Trial I 
Degrees Sum of Mean 
Source of variation freedom square square P-value 
Time periods 8 87.24 10.91 7.68* 
Pigs within 18 25.50 1.42 
time periods 
Tissues 9 2114.01 234.89 234.19* 
Time period x 72 293.38 4.07 4.06* 
tissue inter­
action 
Tissues X pigs l62 l62.4l 1.003 
within time 
periods 
Totals 269 2682.54 252.29 
^Significant at the 0.01 level. 
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Relationships between duration of drug Intake and 
arsenic levels In tissues is illustrated in Figures 5^ 6, 
and ?• The level of arsenic in blood is plotted in each 
of the above figures as a parameter common to all areas of 
the body. 
Comparative amounts of arsenic in blood, muscle and 
rib may be seen in Figure 5. Blood arsenic consistently 
exceeded that present in muscle and rib. Muscle arsenic 
content exceeded 1 part per million in only one group even 
though arsanilic acid was fed at 10 times the recommended 
level for 27 days. 
Comparative amounts of arsenic content of kidney, 
liver, and blood may be seen in Figure 6. Kidney and liver 
retained more arsenic than any other tissues. Blood arsenic 
remained relatively low asi it closely paralleled kidney and 
liver levels. The sudden reduction in arsenic level between 
days 13 and l6 reflected the onset of difficulty in prehen­
sion of feed. 
A comparison of arsenic in blood, peripheral nerves, 
and central nervous system is illustrated in Figure 7. 
Spinal cord, brain stem, cerebellum, and cerebrum arsenic 
levels were averaged and are shown as central nervous system. 
Arsenic in nervous tissue increased more slowly and did not 
fluctuate as rapidly as arsenic levels in the blood. 
Figure 5. Mean parts per million arsenic In blood, muscle, 
and rib during continuous high level feeding 
of arsanlllc acid. Each point on the graph 
represents the mean of three pigs 
TISSUE LEVELS ARSENIC IN PPM 
Figure 6. Mean parts per million arsenic in blood, kidney, 
and liver during continuous high level feeding 
of arsanilic acid. Each point on the graph 
represents the mean of three pigs 
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BLOOD 
KIDNEY 
LIVER 
± J. uL 
4 7 10 13 16 19 21 23 27 
DAYS FED ARSAJIILÎC ACID 900 WTOH RATION 
Figure 7- Mean parts per million arsenic in blood, 
peripheral nerves, and central nervous 
system during high level feeding of arsanlllc 
acid. Each point on the graph represents the 
mean of three pigs. Mean arsenic content of 
spinal cord, brain stem, cerebellum, and 
cerebrum was plotted as a composite of central 
nervous system 
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Gross pathology Gross lesions attributable to 
arsanilic acid toxicosis were not evident. Severe disten­
sion of the urinary bladder occurred in several animals 
that had quadriplegla and were recumbent for 4 days or 
longer. Decubital ulcers were common in all animals with 
posterior paresis or quadriplegla. 
Hlstopathology Detectable histopathologic lesions 
were confined to myelinated nervous tissue. The peripheral 
nerves, optic nerves, and optic tracts were consistently 
affected. 
The neurons of dorsal root ganglia and the ventral gray 
column were examined for degenerative changes referable to 
peripheral nerve damage. In spite of the severe axonal and 
myelin sheath damage noted In peripheral nerves of some 
pigs, no pathologic changes were recognized in the cell 
bodies based on comparisons with controls. 
Slight changes were noted in the myelin sheaths of 
optic nerves and peripheral nerves as early as day 10. 
Pathologic alterations were condensation and contraction of 
myelin sheaths. The areas of contracted myelin were stained 
more deeply eosinophilic than surrounding myelin. On day 
13 the lesions were more pronounced and on day 16 definite 
demyellnation was detected. It was characterized by 
fragmentation and condensation of myelin into globules 
followed by disintegration of axis cylinders. The final 
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result was ovoids of myelin containing axonal fragments. 
With the appearance and progressive development of 
demyellnatlon there was a marked increase of Inflammatory 
cells, mononuclear and polymorphonuclear, first within 
blood vessels and later among the nerve fibers. Most of 
the polymorphonuclear cells were of the eosinophlle type. 
The mononuclear cells had dense, darkly staining nuclei and 
were of the lymphoid type. In some areas the mononuclear 
cells were intimately associated with swollen Schwann cells 
but this was not consistently evident. 
Figure 8 illustrates the histological appearance of a 
peripheral nerve from control animal. Note the neurokeratin 
network of the myelin sheaths surrounding the faintly gray 
axons. Nuclei of Schwann cells are rather large and oval 
shaped. Figure 9 Illustrates the early and Figure 10 the 
advanced lesions in peripheral nerves associated with 
arsanllic acid toxicosis. Note the presence of many darkly 
staining nuclei In Figures 9 and 10 compared to Figure 8. 
A pyknotic Schwann cell nucleus can be seen in Figure 10 
between the arrows labeled with a number 3. 
Figures 11 and 12 Illustrate peripheral nerves from 
control animal stained by Harris hematoxylin and eosln and 
by Bodlans method respectively. In Figure 13 Bodlans method 
was used to demonstrate axonal disintegration. 
Figure 8. Sciatic nerve from control pig. An axon 
appears as a faint gray line between the 
arrows 1. Note darkly stained neurokeratin 
network arrow 2. Harris hematoxylin and 
eosin Y stain. X480 
Figure 9. Sciatic nerve from pig fed arsanilic acid 
(900 gm/ton) for l6 days. Note contraction 
of myelin around intact axon, arrow 1, myelin 
fragment, arrow 2, and myelin ovoid, arrow 3. 
Harris hematoxylin and eosin Y stain. X480 
Figure 10. Sciatic nerve from pig fed arsanilic acid 
(900 gm/ton) for 27 days. Animal had developed 
quadriplegia. An estimated 60 percent of the 
nerve fibers were damaged. Note axon with 
myelin contracting around it, arrow 1, fragment 
of myelin, arrow 2, and fragments myelin con­
taining fragment of axon, arrow 3. Fragmented 
axon is stained darker than the myelin. Harris 
hematoxylin and eosin Y stain. X480 

Figure 11. Sciatic nerve from control pig. Note intact 
axon between arrows. Harris hematoxylin and 
eosin Y stain. X375 
Figure 12. Sciatic nerve from control pig. Note Intact 
axon between arrows. Bodian's stain, X375 
Figure 13. Sciatic nerve from pig fed arsanillc acid 
(900 gm/ton) for I6 days. Note fragmented 
axon of degenerating fiber (arrows). Bodian's 
stain. X375 
57 
58 
Demyellnation In the optic nerves and optic tracts was 
less obvious but essentially paralleled lesions in the 
peripheral nerves. Affected optic tracts and nerves 
appeared more cellular than those in controls. The appear­
ance of increased cellularity was in part due to the swelling 
of neuroglial cells causing them to become more prominent. 
The histological appearance of optic tracts from a 
control animal can be seen in Figures 14, 15, and l6, and 
from an animal which had ingested toxic levels of arsanllic 
acid for 27 days in Figures 17, l8, and 19. Pathologic 
alterations seen in the optic tracts of the latter animal 
were, neuroglial cells with shrunken and pyknotic nuclei, 
fragmentation of myelin sheaths, and diffuse vacuolization 
of the tissue. 
The histological appearance of optic nerves from a 
control animal can be seen in Figures 20, 21, and 22, and 
from an animal fed toxic levels of arsanllic acid for 27 
days in Figures 23, 24, and 25. Histopathologic changes 
noted in the animal receiving arsanllic acid were pyknotic 
nuclei, fragmentation of myelin sheaths and the presence of 
many vacuoles in the tissue. 
Pathological alterations were evident in the heavily 
myelinated fibers of peripheral nerves by days 10-13. 
These alterations had progressed to definite demyellnation 
by day l6. The earliest degenerative change seen in Schwann 
Figure l4. Optic tract from control pig. Harris 
hematoxylin and eosln Y stain. X80 
Figure 15. Optic tract from control pig. Harris 
hematoxylin and eosln Y stain. Xl60 
Figure 16. Optic tract from control pig. Harris 
hematoxylin and eosln Y stain. X4l5 
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Figure 17. Optic tract after 27 days of high level 
arsanilic acid (900 gm/ton) feeding. Note 
appearance of increased cellularity and 
vacuolation. Harris hematoxylin and eosin 
Y stain. X80 
Figure 18. Optic tract after 27 days of high level 
arsanilic acid (900 gm/ton) feeding. Note 
intact axon with contracted myelin, arrow 1, 
and myelin fragments, arrow 2. Harris 
hematoxylin and eosin Y stain. Xl60 
Figure 19. Optic tract after 27 days of high level 
arsanilic acid (900 gm/ton) feeding. Note 
intact axon with contracted myelin, arrow 1, 
fragment of myelin, arrow 2, and myelin 
ovoid containing fragment of axon, arrow 3. 
Harris hematoxylin and eosin Y stain. X4l5 

Figure 20. Optic nerve from control pig. Harris 
hematoxylin and eosln Y stain. X80 
Figure 21. Optic nerve from control pig. Harris 
hematoxylin and eosln Y stain. Xl60 
Figure 22. Optic nerve from control pig. Harris 
hematoxylin and eosln Y stain. X4l5 
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Figure 23. Opblc nerve from pig fed arsanlllc acid 
(900 gm/ton) 27 days. Note appearance of 
Increased cellularlty and presence of 
vacuoles. Harris hematoxylin and eosln Y 
stain. XlOO 
Figure 24. Optic nerve from pig fed arsanlllc acid 
(900 gm/ton) 27 days. Note myelin fragments, 
arrow 1. Harris hematoxylin and eosln Y 
stain. X200 
Figure 25. Optic nerve from pig fed arsanlllc acid 
(900 gm/ton) 27 days. Note myelin contracted 
around axon, arrow 1, and vacuolatIon, arrow 
2. Harris hematoxylin and eosln Y stain. 
X480 

67 
cells associated with initial demyelination was nuclear 
swelling and deeply eosinophilic cytoplasm. With more 
advanced demyelination pyknosis and eventually karyorrhexls 
and karyolysis of Schwann cells were noted. The Schwann 
cells of nonmyelinated fibers did not appear to be affected 
in a similar manner. Demyelination was less apparent in 
the fibers within the dorsal root ganglia. 
An evaluation of peripheral nerve degeneration and 
associated clinical signs is listed in Table 4. Note the 
progressive development of clinical signs and the .pathologic 
changes in peripheral nerves associated with the duration 
of feeding toxic levels of arsanilic acid. 
Trial II 
Effect of withdrawal of arsanilic acid after high level 
feeding 
Tissue retention of arsenic Arsenic determinations 
were made on tissues of pigs that had ingested arsanilic 
acid at 10 times the recommended level (900 gm/ton) for 19 
days and then were f e d a n  arsanilic a c id free ration f o r  3 ,  
6, or 11 days. 
Data from arsenic determinations on tissues of 9 pigs 
are presented in Table 5. The data shown for day 0 were 
taken from day 19 in Table 2 and are a mean tissue arsenic 
in 3 pigs. Data presented for each of the days 3, 6j and 11 
represents mean arsenic content of tissues from 2 pigs. 
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Table 4. Percentage of peripheral nerve fiber degeneration 
and clinical sign manifested by animals^-
Sciatic Femoral Obturator Radial 
Day Clinical sign ^ ^ % 
13 Incoordination 0 0 0 0 
13 Incoordination 0 0 0 0 
13 Incoordination 0 0 0 0 
16 Incoordination 1 1 1 3. 
16 Incoordination 5 2 5 1 
16 Incoordination 2 2 2 1 
19 Posterior paresis 5 2 2 5 
19 Incoordination 1 1 1 1 
19 Incoordination 2 1 2 5 
21 Quadriplegia 30 10 5 5 
21 Posterior paresis 10 5 10 10 
21 Posterior paresis 10 10 10 10 
23 Posterior paresis 10 10 5 5 
23 Posterior paresis 10 5 5 10 
23 Quadriplegia 25 20 10 5 
27 Quadriplegia 60 15 20 10 
27 Quadriplegia 60 10 15 10 
27 Quadriplegia 40 10 10 20 
^Percentage of fibers having undergone degeneration 
was estimated by random counting of normal and damaged 
fibers. 
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Table 5. PPM^ arsenic retained in tissues after feeding 
arsanilic acid (900 gm/ton) for 19 days 
Days after arsanlllc acid withdrawal 
0 3 6 11 
Kidney 8.33 2.90 2.24 1.90 
Liver 9.67 3.10 1.65 1.75 
Muscle 0.92 0.29 0.29 0.31 
Blood 1.94 0.25 0.19 0.45 
Rib 0.46 0.18 0.24 0.08 
Peripheral nerve 1.57 1.17 1.06 0.61 
Spinal cord 0.74 0.76 0.80 0.25 
Brain stem 1.04 0.90 0.91 0.62 
Cerebellum 1.23 1.58 1.10 0.85 
Cerebrum 0.82 1.09 0.84 0.51 
®'Mean parts per million in tissues of three pigs at 
day 0 and two pigs each at day 3, 6, and 11. 
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Arsenic levels decreased rapidly In edible tissues 
following removal of arsanilic acid from the diet. Skeletal 
muscles retained less than one-third of a part per million 
of arsenic 3 days after drug withdrawal. 
Figures 2 6 ,  2?, and 28 illustrate relative levels of 
arsenic retention by various tissues. Skeletal muscle, rib, 
and blood arsenic means are compared In Figure 26. There 
was a rapid decrease in arsenic content In all three tissues 
following removal of arsanilic acid from the diet. 
Mean arsenic content of liver, kidney, and blood are 
compared in Figure 27. Arsenic levels decreased rapidly 
in these tissues after 3 days of withdrawal. Kidney and 
liver arsenic levels remained relatively stable after the 
first 3 days and were 3 to 4 times ater than blood 
arsenic 11 days after arsanilic acid withdrawal. 
Arsenic in blood, peripheral nerves, and central 
nervous system are compared in Figure 28. Mean arsenic 
content of spinal cord, brain stem, cerebellum, and 
cerebrum are plotted as a composite of the central nervous 
system. Blood arsenic decreased rapidly while nervous 
tissue arsenic was more stable. Approximately 50 percent 
of the arsenic in nervous tissue was still retained 11 days 
after withdrawal. 
Figure 29 illustrates the mean percent arsenic retained 
in tissues 3, 6, and 11 days after removal of arsanilic acid 
Figure 26. Mean arsenic content of blood, skeletal 
muscles, and ribs after withdrawal of 
arsanllic acid from diet following 19 days 
of feeding 900 gm/ton ration 
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Figure 27. Mean arsenic content of blood, kidney, and 
liver after withdrawal of arsanillc acid 
from diet following 19 days of feeding 900 
gm/ton ration 
DAYS AFTER ARSANILIC ACID WITHDRAWAL 
Figure 28. Mean arsenic content of blood, peripheral 
nerves, and central nervous system after 
withdrawal of arsanilic acid from diet 
following 19 days of feeding 900 gm/ton 
ration 
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Figure 29. Mean percent arsenic retained in tissues of 
pigs 3J 6, and 11 days after removal of 
arsanilic acid from diet. Mean percentage 
based on mean arsenic level in tissues follow­
ing feeding of arsanilic acid (900 gm/ton) for 
19 days. Nervous tissue represents a composite 
of determinations made on peripheral nerves, 
spinal cord, cerebellum, brain stem, and 
cerebrum 
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from the diet. The peripheral and central nervous system 
arsenic levels are shown as mean nervous tissue arsenic. 
Trial III 
Clinical recovery from arsanlllc acid toxicosis 
Clinical recovery Six pigs were fed a ration con­
taining 10 times the recommended level of arsanlllc acid 
(900 gm/ton) until they had a marked clinical paresis so 
that they were reluctant to or unable to rise to a standing 
position. The shortest time period required to produce 
paresis was 15 days and the longest period 21 days. 
After development of paresis the pigs were maintained 
on an arsanlllc acid free ration for periods of 10 to 38 
days. None of the 6 pigs made a significant clinical 
improvement after removal of arsanlllc acid from the diet. 
Two pigs developed a more severe paresis after removal of 
the drug, however, 1 of these 2 pigs had a suppurative 
cystitis and bilateral hydronephrosis at necropsy. The 
results of Trial III are presented In Table 6. 
Trial IV 
Studies with tritium labeled arsanlllc acid 
Blood clearance and urinary excretion Blood and 
urine samples were collected each hour for 12 hours follow­
ing the Intravenous administration of I.5 mC radioactivity 
in 100 mg arsanlllc acid. The levels of radioactivity in 
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Table 6. Clinical recovery trial from arsanilic acid 
toxicosis 
Days fed Signs at Days off Signs prior 
Pig drug drug withdrawal drug to necropsy 
1^ 18 Posterior paresis 10 Quadriplegia 
2 21 Posterior paresis 12 Unchanged 
3 15 Posterior paresis 17 Unchanged 
4 21 Quadriplegia 20 Unchanged 
5 20 Quadriplegia 32 Unchanged 
6 21 Posterior paresis 38 Quadriplegia 
^Suppurative cystitis and bilateral hydronephrosis 
found at necropsy. 
the various collections, as determined by liquid scintilla­
tion counting, are compiled in Table 7. 
There was a rapid decrease in levels of radioactivity 
in the blood: Four hours post-injection only 0.2 percent 
as much radioactivity remained in the blood as was present 
at one hour post-injection. 
Urinary excretion during the first four hour period 
accounted for approximately 52 percent of the Initial dose. 
The percent of initial dose excreted via the urine over the 
12 hour period is illustrated in Figure 30. 
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Table 7. Blood clearance and urinary excretion of 
trltiated arsanilic acid administered intra­
venously 
Urine 
Post 
injection 
(hour) 
Blood 
dpm/ml 
Volume 
(ml) dpm/ml 
Initial 
dose^ 
(^) 
1 16,900,000 17 3,060,000 1.56 
2 5,320,000 10 115,800,000 34.70 
3 4,220,000 37 9,400,000 10.45 
4 350,000 46 3,800,000 5.26 
5 380,000 20 4,800,000 2.88 
6 180,000 14 14,800,000 6.05 
7 150,000 50 1,520,000 2.27 
8 147,000 26 2,930,000 2.27 
9 107,000 64 400,000 .79 
10 100,200 26 321,000 .25 
11 83,200 31 730,000 .68 
12 117,600 20 1,720,000 1.03 
Totals 361 68.19 
q ^Initial dose contained 1.5 mC radioactivity (3.33 x 
10^ disintegrations per minute). 
Figure 30. Urinary excretion of radioactive material for 
12 hours following the Intravenous adminis­
tration of 1.5 mC radioactivity in 100 mg 
arsanilic acid 
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Distribution of radioactivity at necropsy Samples of 
blood, cerebrospinal fluid, spinal cord, bile, urine, liver, 
and kidney were collected at necropsy for liquid scintilla­
tion counting. The pig had received a second intravenous 
injection of 1.5 mC radioactivity in 100 mg arsanlllc acid 
12 hours after the first injection which was 12 hours prior 
to necropsy. Levels of radioactivity detected in the samples 
collected at necropsy plus the activity present in the com­
posite 24 hour urine sample are listed in Table 8. 
The highest levels of radioactivity detected were in 
urine and bile. Urinary excretion of radioactive materials 
during the 24 hour period accounted for nearly 75 percent 
of the total dose administered. Renal and hepatic tissue 
contained similar levels of radioactivity per gm weight. 
At necropsy the kidneys weighed a total of 12 gm and the 
liver weighed 170 gm. Therefore on a total weight basis the 
liver contained approximately 12 times as much radioactivity 
as the kidneys. 
Whole blood, serum, and blood clot levels of radio­
activity were determined and were found to be approximately 
equal. Cerebrospinal fluid and spinal cord contained the 
lowest levels of radioactivity of the fluids and tissues 
collected In this trial. 
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Table 8. Distribution of radioactivity at necropsy 
Location Radioactivity 
Whole blood 141,000 dpm/ml 
Clotted blood^ 153,000 dpm/ml 
Serum 144,000 dpm/ml 
Cerebrospinal fluid 42,600 dpm/ml 
Spinal cord 38,200 dpm/gm 
Bile 2,795,000 dpm/ml 
Urine^ 5,180,000 dpm/ml 
Liver 362,000 dpm/gm 
Kidney 348,500 dpm/gm 
Composite urine^ 11,070,000 dpm/ml 
s-After removal of serum. 
^Collected from bladder. 
G451 ml collected over 24 hours. 
Autoradiographic findings 
Autoraiiographs of the various tissues were prepared 
with permanent mounts for counting of silver grains. 
Average net counts of silver grains were calculated 
2 for an area 50 t_i in four autoradlographs of each tissue. 
The following net counts were obtained: liver J, kidney 
86 
5.5, optic nerve 1,5, optic tracts 2, medulla 2, spinal 
cord 2.5, dorsal root ganglia 1, and sciatic nerve 1.5. 
The silver grains were spread diffusely over the tissue 
sections with no apparent foci of concentration. 
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DISCUSSION 
This study was designed to experimentally produce 
arsanillc acid toxicosis in pigs in order to evaluate the 
clinical syndrome, gross and microscopic lesions, and to 
measure arsenic content of various tissues. 
The clinical signs were eccontially in agreement with 
the descriptions reported by Oliver and Roe (1957), Jubb 
and Kennedy (1963), and Harding et al. (1968). However, 
there were some differences. One was that symptoms of 
blindness occurred in only one of 39 pigs fed toxic levels 
of arsanillc acid. The test used for evidence of vision 
suggested that the pig was not totally blind, but no 
clinical evaluation was made to determine the degree of 
impaired vision. Some degree of impairment would be 
expected because of the histopathologic changes present 
in the optic nerves and optic tracts. The findings in 
this study suggest that loss of sight is not as common in 
arsanillc acid toxicosis as the aforementioned workers have 
reported. It should be noted that the reports in the litera­
ture do not specify the criteria used for determination of 
blindness. Evaluation of blindness is difficult because an 
intoxicated and Incoordinated animal mimics blindness by 
its manner of gait. 
A roughened hair coat consistently preceded the onset 
of diarrhea by 24-36 hours. Pigs often develop roijgh hair 
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coats prior to or during the onset of diarrhea. This Is 
probably due to a change in fluid balance and possibly 
indicates mild dehydration. Hyperesthesia and incoordina­
tion usually occurred 24-72 hours following the development 
of diarrhea. The observance of this sequence of clinical 
signs should be considered suggestive of arsanlllc acid 
toxicosis in swine receiving this drug in feed or water. 
Oliver and Roe (1957) and Harding et aJ. (1968) reported 
that the removal of arsanlllc acid from the diets of pigs 
showing toxic incoordination, resulted in rapid and nearly 
complete recovery. In Trial III the removal of arsanlllc 
acid from the diets of pigs which had developed posterior 
paresis resulted in either no clinical improvement or the 
progressive development of a more severe paresis. These 
results suggest that symptoms of posterior paresis marks a 
point in the toxic syndrome after which demyellnatlon will 
probably continue to develop despite removal of the drug 
from the diet. Irreversible changes in the Schwann cells 
at this stage could account for the lack of clinical 
Improvement. Another possibility is that retention of 
arsanlllc acid may cause a potentiation of the toxicity to 
nervous tissue. Since regeneration of myelin may require 
2-6 months and the pigs in Trial III were maintained for 
only 38 days after removal of the drug, it cannot be assumed 
that they would not have eventually recovered. These pigs 
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would require more than a reasonable period of time for 
recovery from an economic standpoint. 
In this experiment, pigs which developed incoordina­
tion also suffered a loss of prehensile ability. Loss of 
the latter function became more severe in conjunction with 
the development of posterior paresis and quadriplegla. 
Affected pigs would eagerly ingest feed and water placed in 
their mouths which indicated that there was no loss of 
appetite because of the high levels of arsanilic acid in 
the ration but rather that there was a decreased ability to 
ingest feed. Apparently the cranial nerves controlling the 
muscles used in prehension are also affected in arsanilic 
acid toxicosis. 
Tissue arsenic content was determined at 9 different 
time periods in Trial I in order to determine if there were 
differences among the time periods. The results indicated 
that there was a significant difference in mean tissue 
arsenic among the time periods. These differences reflected 
variations in the relative rates of arsanilic acid intake 
and excretion. During the first 13 days arsanilic acid 
Intake exceeded excretion which resulted in maximum mean 
tissue arsenic levels by the 13th day. After the 13th day 
mean tissue arsenic levels decreased by approximately one-
fourth. This decline coincided with the clinical onset of 
incoordination and diminished prehensile ability which caused 
90 
a decreased feed Intake. 
Arsanlllc acid excretion studies In Trial IV indicated 
that 2 hours after an intravenous administration 36 percent 
of the dose was excreted via the urine. During a 12 hour 
period urinary excretion accounted for 68 percent of the 
initial dose. At necropsy there was evidence of arsanlllc 
acid excretion via the bile but the levels of radioactivity 
per ml was only 20 percent of that in a ml of the 24 hour 
urine sample. These results indicate that arsanlllc acid 
injected intravenously in pigs is rapidly eliminated in the 
urine and to a lesser extent in bile. This is essentially 
in agreement with similar studies done with rats, Voegtlln 
and Thompson (1923), Hogan and Eagle (1944), and with 
rabbits. Chance e_t a^. (1945), Crawford and Levvy (194?). 
The evidence of rapid excretion of arsanlllc acid supports 
the suggestion that variations in the rate of arsanlllc acid 
intake could account for differences in mean arsenic content 
of tissues among the time periods. Due to the rapid elimina­
tion of arsanlllc acid from the body any changes in the rate 
of intake would quickly be reflected in the mean levels 
retained. 
Arsenic determinations in Trial I also indicated that it 
accumulated at different rates and to different levels in the 
various tissues. The retention of different levels of 
arsenic by the various tissues is in agreement with previous 
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reports (Scheldy £t , 1953; Hanson et al., 1955; 
Harding e;t a^., I968).  These reports failed to include 
arsenic levels in nervous tissue and did not indicate the 
relative rates of arsenic accumulation. In Trial I there 
were significant differences in the rates of arsenic 
accumulation by the various tissues. Arsenic content of 
nervous tissue did not reach maximum levels until days I9 
and 21. All other tissues assayed reached maximum levels 
of arsenic on or before day 13. The delayed attainment of 
maximum mean arsenic level in nervous tissue coincides 
approximately with the development of lesions in this tissue. 
Time trends in the accumulation of arsenic by nervous tissue 
suggests an increased binding of arsanilic acid as a result 
of pathological changes. 
Arsenic retention by tissues, following prolonged 
feeding of arsanilic acid at high levels, was investigated 
in Trial II. Mean tissue arsenic was determined 3, 6, and 
11 days following removal of arsanilic acid from the diet. 
Mean percent of arsenic retention was calculated on the basis 
of arsenic in tissues on the 19th day of feeding arsanilic 
acid at the rate of 9OO gm/ton ration. Three days after 
removal of arsanilic acid from the diet skeletal muscle, 
kidnuy, liver, and blood retained 31, 34, 32, and 13 mean 
percent arsenic respectively. The mean percent arsenic 
retained by these tissues remained essentially constant 
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during the following 8 days. Arsenic retention by nervous 
tissue differed markedly. Nervous tissue retained 100, 93, 
and 57 percent arsenic on days 3, 6, and 11 post withdrawal 
respectively. This relatively slow rate of arsenic release 
suggests some form of arsanlllc acid binding unique to 
nervous tissue. This is supported by the results of this 
study indicating that lesions from arsanlllc acid toxicosis 
are primarily limited to the nervous tissue. 
Vorhies et aJ. (1969) indicated that water deprivation 
may be a factor in arsanlllc acid toxicity. Some form of 
water deprivation could be a factor in the field cases of 
arsanlllc acid toxicosis in which pigs with severe diarrhea 
are ingesting therapeutic levels of the drug. Animals with 
severe diarrhea usually become dehydrated and therefore 
have a decreased urinary output. In view of the findings 
in Trial IV that excretion of arsanlllc acid is primarily 
via the urine it is certainly conceivable that anything 
that would reduce urine output could Increase toxicity. 
Another factor to consider Is the possibility of increased 
rate of absorption from the intestinal tract as a result 
of Inflammation. Moody and Williams (1964) reported that 
arsanlllc acid was poorly absorbed from the digestive 
tract of hens. There is no reason to suppose that swine 
absorb arsanlllc acid much more readily than hens. Also it 
is doubtful if an inflamed intestine would absorb arsanlllc 
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acid more readily than a normal intestine. Therefore 
decreased excretion via the urine probably plays a more 
important role in the development of arsanilic acid 
toxicosis than does increased absorption. 
The results from the autoradiographic study in Trial 
IV were inconclusive for the determination of specific 
localization of arsanilic acid in the tissues. The distri­
bution of silver grains indicated that arsanilic acid was 
present throughout the tissues. Relative counts among the 
various tissues tended to reflect the variation in the 
levels of radioactivity detected in those tissues by liquid 
scintillation counting. 
The failure to determine specific localizations of 
arsanilic acid was probably due to the lack of any tissue 
specificity for this drug. A possible solution to the 
problem might be long term administration of tritiated drug, 
15 to 20 days, followed by a 3 day withdrawal period. This 
would allow the excretion of approximately TO percent of the 
arsanilic acid from all tissues except nervous tissue 
according to findings in Trial II of this study. 
Results in Trial IV with tritiated arsanilic acid 
indicated that urine and bile are two important routes for 
the elimination of arsanilic acid. Because of the relative 
levels of radioactivity in each and the volumes excreted, 
urine would have to be considered the primary route of 
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arsanllic acid excretion in pigs. 
Approximately equal levels of radioactivity in whole 
blood, serum, and clotted blood indicated that arsanilic 
acid was evenly distributed between cellular and fluid 
components. Hepatic and renal tissues contained similar 
levels of radioactivity on a per gm basis. The liver 
weighed 170 gm and the kidneys weighed 12 gm thus on a 
total weight basis the liver contained nearly 12 times as 
much radioactivity as the kidneys. Cerebrospinal fluid 
and spinal cord were the least radioactive of the fluids 
and tissues collected in this trial. 
The absence of detectable gross lesions attributable 
to arsanilic acid toxicosis is in agreement with Jubb and 
Kennedy (1963) and Harding et aJ. (1968). Several animals 
which had quadriplegia and were recumbent for 4 days or 
longer did have severe distension of the urinary bladder. 
One of these pigs had a suppurative cystitis and bilateral 
hydronephrosis which was not considered unusual under the 
circumstances of paralyses and prolonged recumbency. 
Detectable histopathologic lesions were confined to 
the myelinated nervous tissue. The peripheral nerves, 
optic nerves, and optic tracts consistently had myelin 
sheath and axonal degenerations. In spite of the severe 
lesions noted in the peripheral nerves of some pigs no 
referable pathologic changes were recognized in the neuron 
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somas located In the dorsal root ganglia or ventral gray 
column. Peripheral neuropathy In the absence of recognizable 
pathological changes In the neuron soma suggests that the 
etiological factors exert their actions on the cells or 
mechanisms which maintain myelin sheaths and axons. 
Pleasure £t aJ. (1969) reported that axoplasmlc flow 
was interrupted in peripheral neuropathy Induced by 
acrylamlde In cats. Axoplasmlc flow was determined by the 
use of tritium labeled L-leucine and autoradiography. In 
normal cats proteins flowed from lumbo-sacral motor neurons 
along the ventral roots and from the dorsal root ganglion 
cells toward the spinal cord at about 1.5 mm per day. 
Interruption of this flow would be accentuated in the motor 
neurons due to the extreme length of their axonal processes. 
Peterson and Murray (I965) described three basic types 
of peripheral demyelination experimentally produced in tissue 
cultures of fetal rat dorsal root ganglia. Demyelination 
was produced by crushing injury, diphtherial toxin, or 
thallium poisoning. Crushing injury produced Wallerlan 
degeneration with primary damage to the axon and myelin 
sheath. Diphtherial toxin produced a segmental demyelina­
tion with primary damage related to individual Schwann cells. 
Neuron soma damage occurred with increased levels of diph­
therial toxin. With neuron soma damage the pattern of 
demyelination changed from segmental to Wallerlan type. 
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Thallium poisoning caused axonal vacuolization without 
disruption of the myelin sheath. It was concluded that 
neuronal somas, axons and Schwann cells differed in their 
individual sensitivity and response to various toxic agents. 
Yonezawa and Iwanami (1966) induced thiamine deficiency 
in cultured nervous tissue by the application of anti­
metabolites, oxythiamine and pyrlthlamine. With low con­
centrations of antimetabolite they could induce a chronic 
form of thiamine deficiency. Degeneration of myelin sheaths 
was the major change. This change was initiated in the area 
close to the Sehwannian nucleus on peripheral fibers. VJith 
high concentrations of antimetabolites an acute form of 
thiamine deficiency was Induced. The changes noted were 
necrosis of neuron somas, oligodendroglla, Schwann cells 
and satellite cells. It was Inferred that there was a dif­
ferent threshold and tolerance for thiamine deficiency in 
myelin-supporting cells and neuron somas. 
In the present study early peripheral nerve degenera­
tion was characterized by condensation and contraction of 
myelin without apparent axonal damage. Later in the toxic 
syndrome there was fragmentation and condensation of myelin 
into globules followed by disintegration of axons. The 
final result was ovolds of myelin containing axonal frag­
ments. In peripheral nerves the more heavily myelinated 
fibers were affected first and nad the most severe lesions. 
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Schwann cells associated with damaged fibers were in 
various stages of degeneration. Some were swollen and 
had eosinophilic cytoplasm while others had pyknotic 
nuclei or were karyorrhectic. Schwann cells of unmyelinated 
fibers did not appear to be affected. 
Fullerton (1966) produced chronic peripheral neuropathy 
by lead poisoning in guinea pigs. Changes noted were 
segmental demyelination or axonal degeneration. When both 
occurred In the same fiber it was indistinguishable from 
Wallerlan degeneration. Large heavily myelinated fibers 
appeared to be more severely affected than small lightly 
myelinated fibers. 
In view of the findings of Peterson and Murray (I965),  
Yonezawa and Iwanami (1966), and Fullerton (1966), it would 
seem that myelin-supportlng cells, axons, and neuron somas 
differ in their sensitivity and response to an individual 
toxic agent. The findings In the present study would 
suggest that there Is a difference in sensitivity and 
response, on the part of the neuron soma, axon and myelin-
supportlng cells, to arsanilic acid. Further these findings 
indicate that myelin-supportlng cells are the most sensitive 
to toxic levels of arsanilic acid. 
The presence of peripheral demyelination with necrosis 
of Schwann cells and a lack of recognizable pathological 
change in the nerve cell bodies indicates that toxic levels 
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of araanlllc acid induces a primary demyelination disease 
in swine. 
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SUMMARY 
The clinical, toxlcologlcal, and pathological aspects 
of arsanilic acid were studied in swine. 
Toxicosis was induced in 27 pigs, average weight 38 
pounds, by feeding arsanilic acid at the level of 0.1 per­
cent of the total ration. One group of three pigs was killed 
and necropsied on day 4, 7, 10, I3, 16, 19, 21, 23 and. 27 after 
the initiation of continuous arsanilic acid feeding. Clinical 
observations were noted daily. Histopathologic and arsenic 
determinations were performed on tissues from each pig. 
The clinical syndrome of toxicosis was characterized 
by transient diarrhea and incoordination early and posterior 
paresis and quadriplegia later- Individual variations in 
susceptibility to the toxic effects of arsanilic acid were 
noted. 
Detectable histopathologlcal changes were confined to 
the optic tracts, optic nerves, and peripheral nerves. 
Major lesions noted were necrosis of myelin-supportlng 
cells and degeneration of myelin sheaths and axons. Lesions 
were first noted after 10 days of feeding the experimental 
ration. There was an obvious Increase in the severity of 
the lesions with the progression of the toxic syndrome. 
Arsenic content of liver, kidney, blood, skeletal 
muscle, ribs, brain, spinal cord, and peripheral nerves 
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was determined for each pig. Maximum mean arsenic levels 
were present In liver, kidney, skeletal muscle, rib, and 
blood on or before day 13 of the experiment. Maximum mean 
arsenic levels in the nervous system were not attained 
until days 19 and 21. 
Six pigs, average weight 40 pounds, were fed arsanilic 
acid at the level of 0.1 percent of the total ration for 19 
days at which time they were fed an arsanilic acid free diet. 
Two pigs were killed and necropsied 3, 6, and 11 days follow­
ing withdrawal of the drug. Tissues from each pig were 
assayed for arsenic content. Three, 6, and 11 days after 
the withdrawal of arsanilic acid skeletal muscle, kidney, 
liver, and blood retained approximately 31, 34, 32, and 13 
mean percent arsenic respectively. Nervous tissue retained 
100, 93, and 57 mean percent arsenic 3, 6, and 11 days post­
withdrawal respectively. 
Arsanilic acid toxicosis was induced in six pigs by 
feeding arsanilic acid In the ration at the 0.1 percent level,. 
The pigs were maintained on this ration until they had 
developed severe posterior paresis or quadriplegia at which 
time they were fed an arsanilic acid free diet. Pigs were 
killed and necropsied on day 10, 12, 17, 20, 32, and 38 
post-withdrawal of drug. Pour pigs had no clinical improve­
ment and two pigs developed a more severe paralysis after 
withdrawal of the drug. 
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One six week old pig weighing 5 kg was used for studies 
with tritiated arsanilic acid. A total dose of 3 mC radio­
activity in 200 mg of arsanilic acid was administered 
intravenously in two equal injections 12 hours apart. 
Urinary excretion over a 24 hour period accounted for 75 
percent of the total dose administered. A much lesser 
amount waa excreted via the bile. Autoradiographic pro­
cedures did not give conclusive evidence as to the specific 
localization of arsanilic acid in tissues. 
These studies support the conclusion that arsanilic 
acid toxicosis induces a primary demyellnating disease in 
swine. 
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